Drug Index



Mechanism :

It is an echinocandin with concentration-dependent inhibition of 1,3-beta-D-glucan synthase resulting in reduced formation of 1,3-beta-D-glucan, an essential polysaccharide comprising 30% to 60% of Candida cell walls.

Indication :

• Esophageal candidiasis

• Treatment of candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses

• Prophylaxis of Candida infections

Contraindications :

Hypersensitivity to micafungin, other echinocandins, or any component of the formulation.

Dosing :

Candidemia, acute disseminated candidiasis, and Candida peritonitis and abscesses:

Premature Neonates >1000 g and Term Neonates: Limited data are available. 7 to 10 mg/kg/dose IV once daily. Doses of 10 to 15 mg/kg/dose IV once daily have been used successfully in the setting of CNS infections.

Premature Neonates <1000 g: Limited data are available. 10 mg/kg/dose IV once daily

1-3 months: 2 mg/kg IV OD. If there is an inadequate clinical response after 5 days, may increase dose to 4 mg/kg/day.

≥4 months: 2 mg/kg IV OD; (Maximum: 100 mg once daily in children <40 kg and 200 mg/day in >40 kg). If there is an inadequate clinical response after 5 days, may increase dose to 4 mg/kg/day.

Duration: At least 14 days after resolution of symptoms or last positive culture, whichever is longer.

Esophageal candidiasis:

1-3 months: 5 to 7 mg/kg/dose IV once daily for 14 to 21 days.

>4 months, ≤30 kg: 3 mg/kg once daily for 14 to 21 days.

>4 months, >30 kg: 2.5 mg/kg once daily; maximum: 150 mg once daily for 14 to 21 days.

Prophylaxis of Candida infection in hematopoietic stem cell transplantation:

1 mg/kg once daily; maximum: 50 mg once daily for 6 weeks.

Adverse Effect :

Abdominal pain, Anemia, Headache, Diarrhea, Increased transaminases, Leukopenia, Nausea Neutropenia, Phlebitis, Pruritus, Pyrexia, Rash, Rigors, Thrombocytopenia, Vomiting, Facial swelling, Vasodilation, Stevens-Johnson syndrome, toxic epidermal necrolysis, shock.

Interaction :

Sirolimus: Micafungin may increase the serum concentration of Sirolimus.
Saccharomyces boulardii: Antifungal Agents may diminish the therapeutic effect of Saccharomyces boulardii.

03/03/2020 19:40:53 Micafungin
ask a doctor
Ask a Doctor
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0